As seen on Outsourcing-Pharma.com - Posted Oct. 8, 2018 - Original Article
| By Francine Lane | Francine Lane, vice president of global transparency at TrialScope, writes an Expert View on the challenges…
NewSpring Capital recognized TrialScope for launching CoronaClinicalTrials.com, a robust search engine that enables everyone to easily find information about COVID-19 treatments and vaccines.
Mike Wenger, TrialScope VP of Patient Engagement, makes a few healthcare tech predictions for 2020.
TrialScope runs the global biopharma industry’s most widely used software for disclosing clinical trial information. The company makes transparency for patients a priority as well.
Industry experts, including TrialScope CEO Jeff Kozloff, reflect on the recent FDA guidance designed to improve diversity in clinical trials.
Resources from the NJEDA, three venture capital firms and proximity to pharmaceutical giants has helped TrialScope support pharmaceutical companies conducting clinical trials globally.
In a bid to increase clinical trial diversity, the FDA published a draft guidance for sponsors. TrialScope CMO Naor Chazan comments on the FDA's move.
TrialScope CEO Jeff Kozloff, a member of the Forbes Technology Council expert panel, shares his insights on communicating complex tech ideas.
Jeff Kozloff, Chief Executive Officer at TrialScope discusses how TrialScope Engage helps clinical trial sponsors connect patients online with clinical trials..
The DIA Inspire Awards honor those who have dedicated themselves to the mission of DIA while also advancing global health.
Large biopharmaceutical companies are expanding their data transparency commitments. smaller organizations are generally lagging in their commitments to clinical data sharing.
Edison Partners is leading a $4 million growth round in Northpass, an enterprise learning solution. The firm’s current investments in New Jersey include TrialScope, Scivantage and Zelis Healthcare.
Clinical trial recruitment is a challenge, but by combining patient engagement with technology, sponsors can take it to the people, says Thomas Wicks, chief strategy officer at TrialScope.
The regulatory process can be grueling for a company trying to get a new drug or medical device to market. TrialScope, a seven-year-old Jersey City-based startup, makes disclosure a little easier.
Vivli was launched in 2015 as a platform for those willing and able to share data. This year, Vivli partnered with TrialScope to offer an end-to-end solution to facilitate disclosure and data sharing.